The Failure of Vytorin and Statins to Improve Cardiovascular Health: Bad Cholesterol Or Bad Theory?
Journal of American Physicians and Surgeons 2008, Fall, 13, 3
-
-
1.0 • 1 Rating
-
-
- $5.99
-
- $5.99
Publisher Description
ABSTRACT The clinical failure of Vytorin in the ENHANCE trial supports the need to reevaluate the efficacy of widespread use of statin drugs for the treatment and prevention of coronary artery disease (CAD).
GENRE
Business & Personal Finance
RELEASED
2008
22 September
LANGUAGE
EN
English
LENGTH
26
Pages
PUBLISHER
Association of American Physicians and Surgeons, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
296.6
KB
Customer Reviews
Cate0101
,
Is this a scam
Says 26 pages. I saw 3
Enhanced Susceptibility to Oxidation and Diminished Vitamin E Content of LDL from Patients with Stable Coronary Artery Disease (Lipids, Lipoproteins, And Cardiovascular Risk Factors)
2001
Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report)
2000
Biochemistry of Cardiovascular Dysfunction in Obesity
2020
Wild-type Food in Health Promotion and Disease Prevention
2008
Fasting Versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?(Perspectives)
2008
Relationship Among Plasma Secretory Phospholipase [a.Sub.2], Oxidized Low Density Lipoprotein & Paraoxonase Activities in Hypertensive Subjects Treated with Angiotensin Converting Enzyme Inhibitors (Report)
2009
Conviction Without a Crime: A True Story (Viewpoint Essay)
2008
Selective Serotonin: Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits?(Report)
2009
Point/Counterpoint: The Case Against Bioidentical Hormones (Drug Overview)
2008
The Need for Clinical Judgment in the Diagnosis and Treatment of Lyme Disease (Report)
2009
Tactics Characteristic of Sham Peer Review (Editorial)
2009
Study of Chelation Therapy should Not be Abandoned.
2009